Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects
Title:
Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects
Author:
Sarashina, Akiko Sesoko, Shogo Nakashima, Mitsuyoshi Hayashi, Naoyuki Taniguchi, Atsushi Horie, Yoshiharu Graefe-Mody, Eva U. Woerle, Hans-Juergen Dugi, Klaus A.